SFM
CLVS

Sphera Funds Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Sphera Funds Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-168,000
Closed -$8.87M – 135
2018
Q1 		$8.87M Buy
168,000
+10,000
+6% +$583K 1.35% 19
2017
Q4 		$10.7M Hold
158,000
– – 1.26% 15
2017
Q3 		$13M Buy
158,000
+65,000
+70% +$5.15M 1.86% 11
2017
Q2 		$8.71M Buy
+93,000
New +$5.69M 1.48% 16
2016
Q3 		– Sell
-200,000
Closed -$2.74M – 121
2016
Q2 		$2.74M Buy
200,000
+105,500
+112% +$1.54M 0.71% 44
2016
Q1 		$1.81M Hold
94,500
– – 0.39% 58
2015
Q4 		$3.31M Sell
94,500
-10,500
-10% -$677K 0.48% 50
2015
Q3 		$9.66M Sell
105,000
-15,000
-13% -$1.3M 1.23% 18
2015
Q2 		$10.5M Buy
120,000
+7,545
+7% +$646K 1.03% 16
2015
Q1 		$8.35M Buy
112,455
+30,500
+37% +$2.15M 0.87% 22
2014
Q4 		$4.59M Sell
81,955
-20,000
-20% -$1.05M 0.78% 38
2014
Q3 		$4.63M Sell
101,955
-3,045
-3% -$127K 0.57% 43
2014
Q2 		$4.35M Buy
105,000
+65,000
+163% +$3.35M 1.07% 28
2014
Q1 		$2.77M Sell
40,000
-5,000
-11% -$367K 0.63% 31
2013
Q4 		$2.71M Buy
+45,000
New +$2.45M 0.76% 33

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return

Sphera Funds Management's CLVS Position: Q2 2018 in Review

Sphera Funds Management sold out of Clovis Oncology, Inc. (CLVS) in Q2 2018, closing a stake of 168,000 shares — an estimated $8.87M sold.

Sphera Funds Management first reported a position in CLVS in Q4 2013 and held it in 15 quarters. The position peaked at $13M in Q3 2017. 210 funds tracked by Wall St. Rank hold CLVS as of Q2 2018.

  • Sphera Funds Management reported no remaining Clovis Oncology, Inc. position as of Q2 2018 after selling out during the quarter.
  • Sphera Funds Management sold 168,000 Clovis Oncology, Inc. shares in Q2 2018, an estimated $8.87M.
  • Sphera Funds Management first reported a position in Clovis Oncology, Inc. in Q4 2013 and held it in 15 quarters.
  • Sphera Funds Management's Clovis Oncology, Inc. position peaked at $13M in Q3 2017.
  • 210 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2018.

Based on Sphera Funds Management's 13F filing for Q2 2018, filed 13 Aug 2018.